Full Press Release Details
Prestige Consumer Healthcare Inc. Expands
CFO Christine Sacco's Role to Include Chief Operating Officer Responsibilities
TARRYTOWN, N.Y., Jan. 6, 2025 (GLOBE NEWSWIRE) - Prestige Consumer
Healthcare Inc. (the "Company" or "Prestige") (NYSE: PBH) today announced that Chief Financial Officer Christine
Sacco's responsibilities have been expanded to include the role of Chief Operating Officer, effective immediately. In this enhanced
position as COO/CFO, Ms. Sacco will oversee the Company's supply chain, in addition to her existing responsibilities. Ms. Sacco
will continue to report to Ron Lombardi, Chief Executive Officer of Prestige.
"Chris' strategic leadership and deep understanding of
our business has been instrumental in our growth and success over her 8 years as CFO," said Ron Lombardi. "This expanded COO/CFO
role positions us to further enhance execution of our strategic initiatives and drive operational excellence across the organization.
Her proven track record in finance combined with her experience working closely with our supply chain operations uniquely positions her
to drive further operational excellence and long-term organic and M&A growth for our Company in this expanded role. "
A seasoned executive with more than 27 years of leadership experience
in the consumer products and specialty pharma space, Ms. Sacco has served as the Company's Chief Financial Officer since 2016. During
her tenure, she has made vital contributions to the Company's strategic transformation and financial success. Under her financial
leadership, the Company has achieved strong sales, earnings and cash flow growth over the past 8 years while positioning Prestige with
significant future capital allocation flexibility to drive further shareholder value.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is a leading consumer
healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's
diverse portfolio of brands include Monistat and Summer's Eve women's health products, BC and Goody's pain
relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness
treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound
W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux's Butt Paste diaper rash ointments,
Nix lice treatment, Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration products and the
Fess line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819